# Trial of Antihypertensive Intervention Management

> **NCT00000513** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Cardiovascular Diseases
- Heart Diseases
- Hypertension
- Vascular Diseases

## Interventions

- **BEHAVIORAL:** diet, reducing
- **BEHAVIORAL:** diet, sodium-restricted
- **DRUG:** chlorthalidone
- **DRUG:** atenolol

## Key facts

- **NCT ID:** NCT00000513
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1984-04
- **Primary completion:** —
- **Final completion:** 1994-11
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000513, "Trial of Antihypertensive Intervention Management". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00000513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*